허문행 (서울대학교 의과대학)님 | 한빛사연구자 > 한빛사

서울대학교 의과대학

최종업데이트 2024.12.26.

Aspirin and HCC risk in MASLD: Nationwide cohort study with genetic risk analysis
- Clin. Mol. Hepatol., Nov 25 2025, | https://doi.org/10.3350/cmh.2025.0528
- 2025-11
- 한빛사논문
AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B
- J. Hepatol., Dec 20 2024, S0168-8278(24)02784-3 | https://doi.org/10.1016/j.jhep.2024.12.029
- 2024-12
- 의약학
- 한빛사논문
[Letter to the Editor] Reply to "A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B: Is cirrhosis driving the performance?"
- J. Hepatol., Nov 08 2024, S0168-8278(24)02700-4 | https://doi.org/10.1016/j.jhep.2024.11.004
- 2024-11
- 의약학
- 한빛사논문
A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B
- J. Hepatol., Aug 30 2024, S0168-8278(24)02494-2 | https://doi.org/10.1016/j.jhep.2024.08.016
- 2024-08
- 의약학
- 한빛사논문
Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study
- Clin. Mol. Hepatol., Jul 2024, 30 (3) | https://doi.org/10.3350/cmh.2024.0055
- 2024-07
- 의약학
- 한빛사논문
Personalized Antiviral Drug Selection in Chronic Hepatitis B Patients Using a Machine Learning Model: A Multinational Study
- Am. J. Gastroenterol., 2023 Mar 7 | DOI: 10.14309/ajg.0000000000002234
- 2023-03
- 의약학
- 한빛사논문

연구자 ID

저자논문